| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |